Sponsors

David Bennett moves to Viapath

  •  

Dr David Bennett, former head of NHS Foundation Trust regulator Monitor, has been appointed the new Chair of Viapath, the pathology joint venture owned by Guy’s and St Thomas’, King’s College Hospital and Serco.

Since its inception in 2009, Viapath has been a UK provider of pathology services to the NHS and private healthcare market. It employs 1300 scientists and other employees and provides one of the widest test repertoires in the NHS.

Other News

Magentus acquires Labflow to expand pathology platform

News

Dec 05, 2025
US and European approval for Roche’s whooping cough POC test

News

Dec 05, 2025
David Thorne appointed as BIVDA's Head of NHS Policy

News

Dec 04, 2025
Validating AI screening for gBRCA mutations directly from pathology slides

News

Dec 04, 2025
BD launches new cell analyser configurations

News

Dec 04, 2025
Immunology workforce report details service under strain

News

Dec 02, 2025
Largest study of nose microbiome highlights Staphylococcus aureus risk

News

Dec 02, 2025
DHSC publishes HIV Action Plan

News

Dec 02, 2025
ICR pushes for expanded prostate cancer screening

News

Dec 02, 2025

Latest Issues

Launch Diagnostics Ltd

Launch Diagnostics provides complete pathology solutions with a comprehensive portfolio of high-quality diagnostic reagents and instrumentation from world leading manufacturers to the Health Services of the United Kingdom. Our associated companies also provide solutions to France, Belgium, and Luxemburg through Launch Diagnostics SAS and to the...

Learn more »

Introduction to bone marrow trephine

Online
9 December, 2025

Fresh muscle biopsies webinar

Online
11 December, 2025

POCT Innovators - The power to disrupt through diagnostics

National Army Museum, Chelsea, London
15 December, 2025

RSM / Path Soc 2026 Winter Meeting

The Royal Society of Medicine, 1 Wimpole St, London, W1G 0AE
20 - 21 January, 2026

BIVDA Regulatory Affairs Seminar

Grand Hotel, Birmingham
10 - 11 February, 2026